Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Read More at https://cointelegraph.com/news/down-99-biotech-firm-180-life-sciences-pivots-crypto-eth?utm_source=rss_feed&utm_medium=rss&utm_campaign=rss_partner_inbound